Sputnik V
Final control point analysis shows 90% efficacy for Russia’s Sputnik V COVID-19 vaccine
December 15, 2020Manufacturing and Production, Research and Development COVID-19, Sputnik V, Vaccine
Efficacy data have been revealed from the final control point data analysis for Russia’s Sputnik V COVID-19 vaccine, showing the …
Russia’s Sputnik COVID-19 vaccine has 91.4% efficacy after 28 days, new interim data show
November 24, 2020Manufacturing and Production, Research and Development COVID-19, Sputnik V, Vaccine
The National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) have released a statement saying …
First interim Phase 3 data shows promise for Russia’s Sputnik V COVID-19 vaccine
November 11, 2020Research and Development COVID-19, Russia, Sputnik V, Vaccine
The first interim Phase 3 data for Russia’s Sputnik V COVID-19 vaccine have been released by the Gamaleya Research Center …
One in seven Russian COVID-19 vaccine recipients display side-effects, says Health Minister
September 18, 2020Medical Communications, Research and Development COVID-19, Russia, Sputnik V, Vaccine
Around one in seven patients who have received Russia’s vaccine against COVID-19 have displayed side-effects in clinical studies, according to …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
